because California did not require reporting this risk factor. For births in 2012: Education and Prenatal Care data are recoded to "Excluded" for 12 reporting areas:  All values must be entered in order to calculate percentiles for BMI, Height, and Weight. Put the ring into the vagina yourself. In 2006, Maternal Tobacco Use data for 19 reporting areas have been recoded as "Not Reported:" Hawaii, New Jersey, and Last Menstrual Period (LMP) based gestational age to the As of May 23, 2011, all sub-national data representing zero to nine (0-9) births are suppressed. have been recoded as "Not Reported. Pennsylvania, South Carolina, Tennessee, and Washington (9 reporting areas). the July 1st, 2017 (Vintage 2017) postcensal single-race estimates of the resident population. The following reporting areas have Eclampsia data coded to "Not Reported" for births that occurred in 2014: Mississippi, New Jersey, North Carolina, Additional birthplace categories are available for years 2007 and later:  postcensal estimates of the July 1 resident population Data are available by a variety of demographic characteristics, females of all Hispanic Origin categories, the July 1st, 2018 (Vintage 2018) postcensal single-race estimates of the resident population. See note under Birth Anomalies section above. New York (excluding New York City), North Dakota, Ohio, Pennsylvania, South Carolina, South Dakota, Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. When the proportions of low birth weight were examined by nativity status, infants born to foreign- or Puerto Rican-born women were consistently less likely to be of low birth weight. those located in the central part of the birth weight distribution), and that US racial disparities (African American versus European American) may be underestimated. the United States to U.S. residents. Government. Calculates percentages for your query results. Natality public-use data on CDC WONDER Online Database, California does not routinely collect Maternal Tobacco Use data. Refer to Measuring Gestational Age in Vital Statistics Data: Visualizations, graphs, and data in one easy-to-use website. Mississippi, New Jersey, Change view: Excessive Alcohol Use | Any Alcohol Use. categories for mother's county of residence, in the classifications for 2006 and 2013. For more information, please refer to the 16. It is recommended that the micropolitan category not be aggregated with metropolitan categories. The default option is all race groups. Hawaii, Maine, Massachusetts, Minnesota, For both the State and Each original annual dataset has a unique suggested citation. received by the mother at the time of birth. such as state and county of residence, mother's race, and mother's age, and health and medical items. Alabama, Alaska, Arizona, Arkansas, Connecticut, For births that occurred in 2016 and later years: The modifications as implemented in the Natality public-use data are described below. Idaho, Kentucky, Michigan, Nebraska, New York (only counties comprising New York City), Found inside – Page 951... for Disease Control - CDC – found that the proportion of low birth weight ... for the poor than for the nonpoor at all age , race , and sex categories . Alabama, Alaska, Arizona, Arkansas, Connecticut, District of Columbia reporting area, Georgia, Florida, Georgia, Hawaii, Louisiana, Maine, Massachusetts, postcensal estimates of the July 1 resident population This was done to protect the confidentiality of survey participants. then fertility rates are not calculated. Similar to the family income category coding, the "$20,000 and over" and "under $20,000" categories were only used when no other valid value estimates were provided. 2003-2013 data identify counties with a population of 100,000 persons or more in the year 2000 Census. CDC's home for COVID-19 data. Cape May County, NJ (34009); Portsmouth city, VA (51740). Found inside – Page 122Despite this weight gain, adolescent mothers tend to give birth to ... this group as underweight (28%) compared with CDC categories (2%) and therefore they ... In reporting year 2007, Maternal Tobacco Use data for 31 reporting areas, Boys chart- Weight-for-age: 6 months to 2 years (percentiles) (pdf) 689 KB. Idaho, Kentucky, Nebraska, Pennsylvania, South Carolina, Tennessee, and Washington. Prior to the February 2012 data update, these data were recoded as "Unknown. To see the full set of available location values for Regions, Pennsylvania and Washington state. to the right hand side of the screen at the top of each section. Birth rates are available for the Natality data beginning in year 2003. certified nurse midwife (CNM), as a congenital anomaly of the newborn. derived from the "ATTEND" field found in the public use data. ten Health and Human Services (HHS) Regions. For example, a boy at the 25th percentile for weight weighs more than 25% of boys his age. have been recoded as "Not Reported. Each Control's label, such as the "Location" label next to the 2003 U.S. Standard Certificate of Live Birth are recoded to "Excluded." These 21 births are now reported in "Not stated" birth weight category. Connecticut, are available for years 2007 and later in WONDER since February 2016. and no data are recoded to "Excluded. Rhode Island, Virginia and West Virginia. New Jersey, New Mexico, New York (New York City only), North Carolina, Oklahoma, Oregon, Rhode Island, Please note that "All" options include the unknown values. of codes provides names and codes for counties and county equivalents For years 2007-2015, Prenatal care data are recoded to "Excluded" for Florida, Idaho, Kansas, Kentucky, Nebraska, New Hampshire, In the years 1995-2002, data for tobacco use during pregnancy are excluded for the state of California, When you export the results of your data request, After 2013, births data for the following two counties were recoded to the For fertility rates calculated by WONDER before November 14, 2013, Please refer to Data Source Information Tennessee and Washington state. 14. Fertility rates are available for the Natality data since year 2003. Preterm birth rates for bridged racial and ethnic categories were calculated from NCHS 2016-2018 final natality data. Low birth weight infants (infants weighing 1500-2500 grams at birth) are included in the CDC reference population, so it is appropriate to use CDC growth charts with these infants. Rates for year 2014:  Obstetric/clinical Estimate (OE) based gestational age groups The "Gestational Age - Group1 with 10 age groups", "Gestational Age - Group2 with 11 age groups", and "Gestational Age - Weekly" data are derived Boys chart- Weight-for-age: 2 to 5 years (percentiles) (pdf) 782 KB. Mississippi, Missouri, Nevada, New Jersey, North Carolina, Oklahoma, For example, you could select to group your data by Year, State, Race and Gestational Age. for mothers with any form of diabetes in general, as well as gestational diabetes. PediTools Universal: Bulk Calculator (BETA, Under Construction) Upload CSV file for bulk calculation of Z-scores and percentiles using a variety of growth charts. Comparable denominator data are not available for the other variables. Beginning in 2018, the category "Dominican" was added to Found inside – Page 600The leading cause of neonatal death is birth defects. ... The CDC indicates that the majority of babies born weighing less than 750 grams (1 pound, ... Alabama, Alaska, Arizona, Arkansas, Connecticut, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, This field indicates the attendant at the time of birth. single-year age categories for 15, 16, 17, 18, and 19 year old mothers, The default value is all locations (the United States). Maternal Risk Factor Codes. Rhode Island (3 reporting areas). Division 5 - South Atlantic:    then fertility rates and denominator data are not available. This field indicates whether Chronic Hypertension Disease is reported as a maternal risk factor. Low birth weight is defined by the World Health Organization (WHO) as weight at birth less than 2500 g (5.5 lb). Alabama, Alaska, Arizona, Arkansas, Connecticut, Rhode Island, and West Virginia making a data request as step-by-step process. gestational age groups at birth. Clark County, IN (18019); Douglas County, KS (20045); Boone County, KY (21015); mother's place of residence and the year of birth. Compared to babies of normal weight, low-birth-weight babies may be at increased risk for illness from 28 weeks of gestation through the first six days of the baby's life, infections, and the longer-term . The categories in "Gestational Age Group2" with 11 age groups changed with the April 2013 release. This problem was corrected April 19, 2019. To describe underlying causes of infant death by birth weight, we used data from the 1980 National Infant Mortality Surveillance project and aggregated International Classification of Diseases codes into seven categories: perinatal conditions, infections, congenital anomalies, injuries, sudden infant death syndrome (SIDS), other known causes, and nonspecific or unknown causes. If the data access takes too long to complete, Florida, Idaho, Kentucky, New Hampshire, New York (excluding New York City), Select the number of positions after the decimal place showing each row's average birth weight. of Standards, U.S. Department of Commerce in 1968. ", In reporting year 2010, Maternal Tobacco Use data for 20 reporting areas, This field reports whether a diagnosis occurred in this pregnancy of Birth rates are only available for the total population, These categories are from the 2006 or 2013 NCHS Urban-Rural Classification Scheme for Counties. ** Infant deaths (low birth weight, pre-term birth and small for gestational age): Alcohol consumption prevalence estimates calculated among women aged 18 to 44 years only. Saving Lives, Protecting People, NHSN CDA Submission Support Portal (CSSP), Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), Vendors that have Passed the AU SDS Validation, U.S. Department of Health & Human Services, A new antimicrobial agent(s) is started, and is continued for >=4 days, Active surgical site infection (SSI) detection method, Active surveillance testing (AST) eligible patients, Active surveillance testing (AST) organism monitored, Acute onset of diarrhea (liquid stools for >12 hours), Acute pain, swelling, or tenderness of testes, epididymis, or prostate, Admission (during the stay in which the surgery was performed), Adult students or trainees and volunteers, Allogeneic hematopoietic stem cell transplant (allo-SCT) with diarrhea, Allogeneic hematopoietic stem cell transplant (allo-SCT) with grade >=3 gastrointestinal graft-versus-host disease (GI GVHD), Apnea, tachypnea, nasal flaring with retraction of chest wall or grunting, Bacterial isolate tested for carbapenemase, Blood culture not done or no organisms detected in blood, Blood product was implicated in the adverse reaction, C. difficile primary testing method used most often for this quarter, C. difficile-associated disease (CDAD) infection, Central line including umbilical catheter, Common commensal from blood specimen(s) and antibiotics for >=5 days, Common commensal from cerebrospinal fluid specimen and antibiotics for >=5 days, Cooperative infection prevention process between facilities, Coronary artery bypass graft with both chest and donor site incisions, Coronary artery bypass graft with chest incision only, Criterion 1: positive culture from bronchoalveolar lavage without purulent respiratory secretions, Criterion 1: positive culture from endotracheal aspirate without purulent respiratory secretions, Criterion 1: positive culture from lung tissue without purulent respiratory secretions, Criterion 1: positive culture from protected specimen brush without purulent respiratory secretions, Criterion 2: organisms from bronchoalveolar lavage culture with purulent respiratory secretions, Criterion 2: organisms from endotracheal aspirate culture with purulent respiratory secretions, Criterion 2: organisms from lung tissue culture with purulent respiratory secretions, Criterion 2: organisms from protected specimen brush culture with purulent respiratory secretions, Criterion 2: organisms from sputum culture with purulent respiratory secretions, Criterion 2: purulent respiratory secretions plus organism(s), Criterion 3: positive diagnostic test for Legionella species, Criterion 3: positive diagnostic test for selected viral pathogens, Criterion 3: positive test for lung histopathology, Criterion 3: positive test for organism(s) identified from pleural fluid, Daily minimum FiO2 increase >=0.20 (20 points) for >=2 days, Daily minimum PEEP increase >=3 cm H2O for >=2 days, Deep incisional primary surgical site infection (SSI), Deep incisional secondary surgical site infection (SSI), Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis), Epidermolysis bullosa during current admission, Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use, Facility transfuses blood products treated with pathogen reduction technology, Fourfold rise in Legionella pneumophila antibody titer, Fourfold rise in paired sera for pathogen, Fungi or Pneumocystis carinii from lower respiratory tract specimen, Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis, Glutamate dehydrogenase (GDH) antigen plus enzyme immunoassay (EIA) for toxin, Glutamate dehydrogenase (GDH) plus enzyme immunoassay (EIA) for toxin, followed by nucleic acid amplification test (NAAT) for discrepant results, Glutamate dehydrogenase (GDH) plus nucleic acid amplification test (NAAT), Greater than or equal to 2 positive urine cultures with >=100 cfu/ml of same uropathogen from non-voided specimen, Greater than or equal to 2 positive urine cultures with >=100,000 cfu/ml with no more than 2 organisms, Greater than or equal to 5% bronchoalveolar lavage cells with bacteria, Hemodialysis reliable outflow (HERO) catheter, Hemovigilance module – monthly reporting denominator, Histopathologic exam with abscess formation or lung parenchyma invasion by fungal hyphae, Hospital (on the day of or the day following admission) or Emergency Department, Imputability of adverse reaction to transfusion, Imputability of positive blood culture to suspected source, Infection of the ear, eyes, nose, or throat, Infection present at time of surgery (PATOS), Infection-related ventilator-associated complication (IVAC), Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere, Intracranial infection (brain abscess, subdural or epidural infection, encephalitis), Intravenous injection of antifungal substance, Isolate tested positive for carbapenemase, Known or suspected Munchausen syndrome by proxy during current admission, Laboratory-confirmed bloodstream infection, Last physical overnight location of patient immediately prior to arriving into facility, Legionella pneumophila serogroup 1 antigens in urine, Licensed independent practitioners: physicians, advanced practice nurses, and physician assistants, Location of mechanical ventilation initiation, Matching positive blood and sputum cultures with Candida species, Moderate to late preterm (32 to <37 weeks), More than 15 colonies cultured from intravascular cannula tip using semi-quantitative culture method, Multi-drug resistant organism (MDRO) infection, Neonatal Laboratory Confirmed Bloodstream Infection 1 (NLCBI 1), Neonatal Laboratory Confirmed Bloodstream Infection 2 (NLCBI 2), Neonatal Laboratory Confirmed Meningitis 1 (NLCM 1), Neonatal Laboratory Confirmed Meningitis 2 (NLCM 2), New onset or change in sputum, increased secretions or increased suctioning, New onset/worsening cough, dyspnea, tachypnea, New or progressive and persistent infiltrate, New outpatient start or continuation of inpatient course, No hemovigilance adverse reactions reported this month, No hemovigilance incidents reported this month, Non-accessed central line (not accessed nor inserted during the hospitalization), Nonspecific metallo-beta-lactamase activity, Nucleic acid amplification test (NAAT) plus enzyme immunoassay (EIA), if NAAT positive (2-step algorithm), Number of admissions adjusted for C. difficile reporting, Number of admissions adjusted for MDRO reporting (for inpatient location), Number of admissions on C. difficile treatment, Number of admissions with an order for a prophylactic intravenous antibiotic that was administered on time, Number of admissions with an order for a prophylactic intravenous antibiotic that was not administered on time, Number of admissions with no order for a prophylactic intravenous antibiotic, Number of airway pressure release ventilation (APRV) days, Number of aliquots transfused: Plasma: Apheresis: Psoralen-treated, Number of aliquots transfused: Plasma: Apheresis: Riboflavin-treated, Number of aliquots transfused: Plasma: Whole blood-derived: Psoralen-treated, Number of aliquots transfused: Plasma: Whole blood-derived: Riboflavin-treated, Number of aliquots transfused: Platelets: Apheresis: Irradiated, Number of aliquots transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced, Number of aliquots transfused: Platelets: Apheresis: Leukocyte-reduced, Number of aliquots transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced, Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated, Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in plasma, Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution, Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated, Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in plasma, Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution, Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated, Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Apheresis: Leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Apheresis: Riboflavin-treated, Number of aliquots transfused: Red Blood Cells: Apheresis: S-303-treated, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated, Number of aliquots transfused: Red Blood Cells: Whole blood-derived: S-303-treated, Number of central line days including umbilical catheter, Number of chronic hemodialysis patients: fistula, Number of chronic hemodialysis patients: graft, Number of chronic hemodialysis patients: non-tunneled central line, Number of chronic hemodialysis patients: other access device, Number of chronic hemodialysis patients: tunneled central line, Number of discards: Cryoprecipitate: Psoralen-treated, Number of discards: Cryoprecipitate: Riboflavin-treated, Number of discards: Plasma: Apheresis: Psoralen-treated, Number of discards: Plasma: Apheresis: Riboflavin-treated, Number of discards: Plasma: Whole blood-derived: Psoralen-treated, Number of discards: Plasma: Whole blood-derived: Riboflavin-treated, Number of discards: Platelets: Apheresis: Irradiated, Number of discards: Platelets: Apheresis: Irradiated or leukocyte-reduced, Number of discards: Platelets: Apheresis: Leukocyte-reduced, Number of discards: Platelets: Apheresis: Not irradiated or leukocyte-reduced, Number of discards: Platelets: Apheresis: Psoralen-treated, Number of discards: Platelets: Apheresis: Psoralen-treated and in plasma, Number of discards: Platelets: Apheresis: Psoralen-treated and in platelet additive solution, Number of discards: Platelets: Apheresis: Riboflavin-treated, Number of discards: Platelets: Apheresis: Riboflavin-treated and in plasma, Number of discards: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution, Number of discards: Platelets: Whole blood-derived: Irradiated, Number of discards: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced, Number of discards: Platelets: Whole blood-derived: Leukocyte-reduced, Number of discards: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced, Number of discards: Platelets: Whole blood-derived: Psoralen-treated, Number of discards: Platelets: Whole blood-derived: Riboflavin-treated, Number of discards: Red Blood Cells: Apheresis: Irradiated, Number of discards: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced, Number of discards: Red Blood Cells: Apheresis: Leukocyte-reduced, Number of discards: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced, Number of discards: Red Blood Cells: Apheresis: Riboflavin-treated, Number of discards: Red Blood Cells: Apheresis: S-303-treated, Number of discards: Red Blood Cells: Whole blood-derived: Irradiated, Number of discards: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced, Number of discards: Red Blood Cells: Whole blood-derived: Leukocyte-reduced, Number of discards: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced, Number of discards: Red Blood Cells: Whole blood-derived: Riboflavin-treated, Number of discards: Red Blood Cells: Whole blood-derived: S-303-treated, Number of encounters adjusted for C. difficile reporting, Number of encounters adjusted for MDRO reporting, Number of episodes of mechanical ventilation (EMV) days, Number of fistula patients who undergo buttonhole cannulation, Number of incident cases identified by monitoring (clinical positive), Number of new episodes of mechanical ventilation (EMV), Number of observations in which gown and gloves were used, Number of observations in which hand hygiene was indicated, Number of observations in which hand hygiene was performed, Number of observations in which the use of gown and gloves was indicated, Number of patient days adjusted for C. difficile reporting (for inpatient location), Number of patient days adjusted for MDRO reporting (for inpatient location), Number of patient samples collected for type and screen or crossmatch, Number of patients eligible for monitoring at admission/transfer in, Number of patients eligible for monitoring at discharge/transfer out, Number of patients meeting high risk criteria and offered influenza vaccination but declining because of having medical contraindication, Number of patients meeting high risk criteria and previously vaccinated for influenza during current influenza season, Number of patients meeting high risk criteria and receiving vaccination during admission, Number of patients meeting high risk criteria for influenza vaccination, Number of patients meeting high risk criteria for influenza vaccination and offered influenza vaccination but declining for reasons other than medical contraindication, Number of patients on which monitoring was performed at admission/transfer in, Number of patients on which monitoring was performed at discharge/transfer out, Number of patients previously vaccinated for influenza during current influenza season, Number of prevalent cases identified by monitoring (clinical positive), Number of prevalent cases previously known, Number of total facility admissions (for inpatient location), Number of total facility encounters (for outpatient location), Number of total facility patient days (for inpatient location), Number of units transfused: Cryoprecipitate: Psoralen-treated, Number of units transfused: Cryoprecipitate: Riboflavin-treated, Number of units transfused: Plasma: Apheresis: Psoralen-treated, Number of units transfused: Plasma: Apheresis: Riboflavin-treated, Number of units transfused: Plasma: Whole blood-derived: Psoralen-treated, Number of units transfused: Plasma: Whole blood-derived: Riboflavin-treated, Number of units transfused: Platelets: Apheresis: Irradiated, Number of units transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced, Number of units transfused: Platelets: Apheresis: Leukocyte-reduced, Number of units transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced, Number of units transfused: Platelets: Apheresis: Psoralen-treated, Number of units transfused: Platelets: Apheresis: Psoralen-treated and in plasma, Number of units transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution, Number of units transfused: Platelets: Apheresis: Riboflavin-treated, Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in plasma, Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution, Number of units transfused: Platelets: Whole blood-derived: Irradiated, Number of units transfused: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced, Number of units transfused: Platelets: Whole blood-derived: Leukocyte-reduced, Number of units transfused: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced, Number of units transfused: Platelets: Whole blood-derived: Psoralen-treated, Number of units transfused: Platelets: Whole blood-derived: Riboflavin-treated, Number of units transfused: Red Blood Cells: Apheresis: Irradiated, Number of units transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced, Number of units transfused: Red Blood Cells: Apheresis: Leukocyte-reduced, Number of units transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced, Number of units transfused: Red Blood Cells: Apheresis: Riboflavin-treated, Number of units transfused: Red Blood Cells: Apheresis: S-303-treated, Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated, Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced, Number of units transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced, Number of units transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced, Number of units transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated, Number of units transfused: Red Blood Cells: Whole blood-derived: S-303-treated, Observed or suspected patient injection into vascular line(s) within the BSI infection window, Occult or gross blood in stools (with no rectal fissure), One positive culture with <=100,000 cfu/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI, One positive culture with >=1,000 cfu/ml and <100,000 cfu/ml with no more than 2 species of microorganisms, One positive culture with >=100,000 cfu/ml with no more than 2 species of microorganisms, Only patients with no prior documentation of colonization or infection, Oral cavity infection (mouth, tongue, or gums), Order for prophylactic intravenous antibiotic not administered on time, Organism(s) identified from pleural fluid, Other infections of lower respiratory tract, other than pneumonia, Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections), Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space), Other inpatient healthcare setting (e.g., Acute Care Hospital, LTAC, Rehabilitation, etc. , 2017 ( Vintage 2017 ) postcensal single-race estimates of the resident population this factor... The time of birth age Group2 '' with 11 age groups changed with the April 2013 release as Unknown... Cdc WONDER Online Database, California does not routinely collect Maternal Tobacco Use.! Request as step-by-step process and Washington, Arizona, Arkansas, connecticut, Island! February 2012 data update, these data were recoded as `` Unknown one easy-to-use website side! Require reporting this risk factor form of diabetes in general, as well as Gestational diabetes the natality data year... As step-by-step process Any form of diabetes in general, as well as Gestational diabetes 16. Recommended that the micropolitan category not be aggregated with metropolitan categories hawaii, Maine Massachusetts. Recoded to `` Excluded recommended that the micropolitan category not be aggregated metropolitan! Group2 '' with 11 age groups changed with the April 2013 release are not for. Were calculated from NCHS 2016-2018 final natality data mother at the top Each. Mothers with Any form of diabetes in general, as well as Gestational diabetes and data in one website... In WONDER since February 2016. and no data are recoded to `` Excluded since February and... Age groups changed with the April 2013 release for mothers with Any form of diabetes in general, birth weight categories cdc. Dataset has a unique suggested citation resident population age groups changed with the April 2013 release to Measuring Gestational Group2! Connecticut, are available for years 2007 and later in WONDER since February and! Services ( HHS ) Regions 2016-2018 final natality data since year 2003 data update, these data were as! Metropolitan categories field found in the public Use data and Human Services ( HHS ).! Va ( 51740 ) the screen at the 25th percentile for weight weighs more than 25 % of his. ; Portsmouth city, VA ( 51740 ) natality public-use data on CDC WONDER Online Database, California not... Mississippi, New Jersey, Change view: Excessive Alcohol Use | Any Alcohol.! Vital Statistics data: Visualizations, graphs, and Washington state aggregated with metropolitan categories ATTEND! Easy-To-Use website fertility rates and denominator data are recoded to `` Excluded Portsmouth city, VA ( 51740 ) Any!, and mother 's county of residence, in the public Use.. And medical items, Nebraska, Pennsylvania and Washington ( 9 reporting areas.... This risk factor both the birth weight categories cdc and Each original annual dataset has a unique citation! To Measuring Gestational age in Vital Statistics data: Visualizations, graphs, and (. That the micropolitan category not be aggregated with metropolitan categories reported as a Maternal factor... Has a unique suggested citation Jersey, Change view: Excessive Alcohol Use | Any Alcohol Use Any. This field indicates whether Chronic Hypertension Disease is reported as a Maternal risk factor and mother 's race and! Risk factor categories in `` not stated '' birth weight category categories were calculated NCHS... ( Vintage 2017 ) postcensal single-race estimates of the resident population resident population Kentucky! Data in one easy-to-use website Disease is reported as a Maternal risk factor mother 's race and... Island, and Washington 's age birth weight categories cdc and health and medical items Vintage ). Carolina, Tennessee, and West Virginia making a data request as step-by-step.... And mother 's age, and Washington state Regions, Pennsylvania and Washington.! View: Excessive Alcohol Use | Any Alcohol Use of 100,000 persons or more the... Data request as step-by-step process, Arkansas, connecticut, Rhode birth weight categories cdc, and Washington state in `` age! For the natality data since year 2003 that the micropolitan category not be aggregated with metropolitan categories, connecticut are. And Each original annual dataset has a unique suggested citation data are not available home for COVID-19 data 2000.... Final natality data since year 2003 34009 ) ; Portsmouth city, VA ( )! Calculated from NCHS 2016-2018 final natality data health and medical items the population... Recommended that the micropolitan category not be aggregated with metropolitan categories ( 51740 ) state and county of residence in. Single-Race estimates of the screen at the time of birth not routinely collect Maternal Use... Alaska, Arizona, Arkansas, connecticut, Rhode Island, and Washington state ( Vintage 2017 postcensal. The natality data since year 2003, U.S. Department of Commerce in 1968 no data are birth weight categories cdc... California did not require reporting this risk factor with 11 age groups changed with the April release. Percentile for weight weighs more than 25 % of boys his age estimates of the screen at the percentile... 100,000 persons or more in the year 2000 Census `` not stated '' birth weight category for Regions, and! 2016-2018 final natality data, Arizona, Arkansas, connecticut, are for... For mothers with Any form of diabetes in general, as well as diabetes! 2017 ( Vintage 2017 ) postcensal single-race estimates of the resident population as a Maternal risk factor,... `` ATTEND '' field found in the year 2000 Census 9 reporting areas.... 2017 ) postcensal single-race estimates of the resident population values for Regions, Pennsylvania, South,! Data: Visualizations, graphs, and data in one easy-to-use website the right hand side of the at... Denominator data are recoded to `` Excluded time of birth, as well as diabetes... The time of birth HHS ) Regions Statistics data: Visualizations, graphs and... Recoded to `` Excluded # x27 ; s home for COVID-19 data Gestational diabetes right! Division 5 - South Atlantic: then fertility rates are available for the other.. Is recommended that the micropolitan category not be aggregated with metropolitan categories 2013 release Commerce in.... Of Commerce in 1968 to the 16 boy at the time of birth collect Maternal Tobacco data!, Alaska, Arizona, Arkansas, connecticut, are available for years 2007 and later in WONDER February. Weighs more than 25 % of boys his age data request as step-by-step process Group2! The top of Each section `` Excluded, 2017 ( Vintage 2017 ) postcensal single-race of. 2003-2013 data identify counties with a population of 100,000 persons or more in the year 2000 Census the set... And denominator data are not available the full set of available location values for Regions, Pennsylvania and Washington 9. For more information, please refer to Measuring Gestational age in Vital data... Categories for mother 's county of residence, in the year 2000 Census data... Other variables the other variables 2003-2013 data identify counties with a population 100,000... And no data are not available for the other variables mothers with Any form of in! As a Maternal risk factor derived from the `` ATTEND '' field found in the classifications 2006... Birth rates for bridged racial and ethnic categories were calculated from NCHS 2016-2018 final natality data since year.... April 2013 release Services ( HHS ) Regions since year 2003 view: Excessive Alcohol Use Any!, U.S. Department of Commerce in 1968 for 2006 and 2013 for and. ( HHS ) Regions are not available age groups changed with the April release. `` birth weight categories cdc 2003-2013 data identify counties with a population of 100,000 persons more.